Editorial - (2011) Volume 2, Issue 6

Development of Novel Anti-aging Drugs

Fumiaki Uchiumi1,2*, Takahiro Oyama1, Kensuke Ozaki1 and Sei-ichi Tanuma2,3
1Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-shi, Chiba-ken, Japan
2Research Center for RNA Science, RIST, Tokyo University of Science, Noda-shi, Chiba-ken, Japan
3Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-shi, Chiba-ken, Japan
*Corresponding Author: Fumiaki Uchiumi, Ph.D., Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba-ken 278-8510, Japan, Tel: +81-4-7121-3616, Fax: +81-4-7121-3608 Email:


It has been thought that cellular senescence is regulated by the total amount of damage to chromosomes, including telomeric regions. Another explanation is that cellular senescence is attributed to oxidative stresses mainly generated in mitochondria. At present, several compounds, such as 2-deoxy-D-glucose (2-DG) and trans- Resveratrol (Rsv), are expected to be used as anti-aging drugs for extending life-span. Our previous study indicated that promoter activities of the telomere-maintenance factor-encoding genes are activated by both compounds. The mechanism might be implicated in the concept of hormesis - that the application of low doses of toxic substrates strengthens DNA-repair system. Effective anti-aging drugs could be found by screening compounds that up-regulate expression of the telomere associated genes.

Keywords: Caloric restriction; Cellular senescence; 2-deoxy-Dglucose; Oxidative stress; Resveratrol


All higher organisms, including humans, experience aging and have limited life spans. It has been explained that the aging process is controlled by damage to chromosomes [1] and oxidative stress [2,3]. Telomeres, which are the ends of chromosomes, are composed of TTAGGG repeats with the maintenance factor complex [4]. Repeated replication shortens telomeres [5] and causes chromosomal instability to arise [4]. Mutations of specific genes, such as WRN and LMNA, are known to cause premature aging syndromes [6,7]. The proteins that are encoded on these genes are thought to regulate chromosomal stability and probably the telomere maintenance system. From studies of model organisms, several genes that encode anti-oxidative enzymes, insulinsignaling proteins, sirtuin (Sir2 in yeast, and SIRT1 in mammalian organisms), tumor suppressor p53, and transcription factor FoxO were shown to affect lifespan [8,9]. These lines of evidence raised the question: how do chromosomal damage and oxidative stress associate with each other to properly regulate the aging process and how can expanding our knowledge of these processes and their association aid in the development of effective anti-aging drugs?

Reactive oxygen species (ROS), which are mainly generated from mitochondria, are thought to cause DNA damage [10]. Recently, it was revealed that telomere dysfunction exerts a signal to mitochondria by reducing transcription of the PGC-1α and PGC-1β genes that encode mitochondrial regulators [11]. These observations suggest that there is mutual communication between mitochondoria and telomeres

To date, several candidates for anti-aging drugs have been investigated. For example, 2-deoxy-D-glucose (2DG), which is a potent inhibitor of glucose metabolism, has a caloric restriction (CR) mimetic effect [12]. The natural compound Resveratrol (Rsv), which is contained in grape skins and red wine, activates sirtuin-mediated deacetylation [13]. The life spans of various organisms might be extended by administration of these drugs [12,14]. Besides affecting glucose metabolism and sirtuins, these CR mimetic compounds have the effect of inducing transcription of telomere-associated genes. Our previous study indicated that 2DG and Rsv up-regulate the promoter activities of the WRN, TERT, and shelterin-encoding genes, along with moderately stimulating telomerase activity [15-17]. This might be a favorable side effect, and may shed light in the search for anti-aging drugs. The anti-aging effect might come from the concept of hormesis [18], the stimulation of the DNA repair or telomere-maintenance system through low doses of toxic substrates. By analyzing the stimulation of telomerase and the gene expression of the telomeremaintenance factors, effective anti-aging drugs might be discovered, isolated, and synthesized in the future.


  1. Vijg J (2007) Chapter 5: Genome instability and accelerated aging. In: Aging of the Genome: The Dual Role of DNA in Life and Death, Oxford University Press, NY: 151-180.
  2. Robb EL, Page MM, Stuart JA (2009) Mitochondria, cellular stress resistance, somatic cell depletion and lifespan. Curr Aging Sci 2: 12-27.
  3. Benz CC, Yau C (2008) Ageing, oxidative stress and cancer: paradigms in parallax. Nat Rev Cancer 8: 875-879.
  4. O'Sullivan RJ, Karlseder J (2010) Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol 11: 171-181.
  5. Blackburn E (2006) Chapter 1: A history of telomere biology. In: Telomeres (2nd edn) (de Lang T, Lundblad V, Blackburn E, Eds.), Cold Spring Harbor Laboratory Press, NY: 1-19.
  6. Chu WK, Hickson ID (2009) RecQ helicases: multifunctional genome caretakers. Nat Rev Cancer 9: 644-654.
  7. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, et al. (2003) Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423: 293-298.
  8. Kuningas M, Mooijaart SP, van Heemst D, Zwaan BJ, Slagboom PE, et al. (2008) Genes encoding longevity: from model organisms to humans. Aging Cell 7: 270-280.
  9. van der Horst A, Burgering BTT (2007) Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 8: 440-450.
  10. Oberdoerffer P, Sinclair DA (2007) The role of nuclear architecture in genomic instability and aging. Nat Rev Mol Cell Biol 8: 692-702.
  11. Sahin E, Colla S, Liesa M, Moslehi J, Müller FL, et al. (2011) Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470: 359-365.
  12. Roth GS, Ingram DK, Lane MA (2001) Caloric restriction in primates and relevance to humans. Ann N Y Acad Sci 928: 305-315.
  13. Stefani M, Markus MA, Lin RC, Pinese M, Dawes IW, et al. (2007) The effect of resveratrol on a cell model of human aging. Ann N Y Acad Sci 1114: 407-418.
  14. Kaeberlein M (2010) Resveratrol and rapamycin: are they anti-aging drugs? Bioessays 32: 96-99.
  15. Zhou B, Ikejima T, Watanabe T, Iwakoshi K, Idei Y, et al. (2009) The effect of 2-deoxy-D-glucose on Werner syndrome RecQ helicase gene. FEBS Lett 583: 1331-1336.
  16. Uchiumi F, Watanabe T, Hasegawa S, Hoshi T, Higami Y, et al. (2011) The effect of resveratrol on the Werner Syndrome RecQ helicase gene and telomerase activity. Curr Aging Sci 4: 1-7.
  17. Uchiumi F, Oyama T, Ozaki K, Tanuma S (2011) Characterization of 5'-flanking regions of various human telomere maintenance factor-encoding genes, In: DNA Repair (Kruman I, Ed.), InTech-Open Access Publisher, Inc, Rijeka, Croatia, in press.
  18. Schumacher B (2009) Transcription-blocking DNA damage in aging: a mechanism for hormesis. Bioessays 31: 1347-1356.
Citation: Uchiumi F, Oyama T, Ozaki K, Tanuma SI (2011) Development of Novel Anti-aging Drugs. Pharm Anal Acta 2:106e.

Copyright: © 2011 Uchiumi F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.